Please login to the form below

Not currently logged in
Email:
Password:

miRagen Therapeutics

This page shows the latest miRagen Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Oncology bias in pharma deals

disease) to Newron Pharmaceuticals, triggered the termination of Biotie Therapeutics' acquisition of Newron. ... 370. miRagen Therapeutics/Servier. R&D and commercialisation licence (option to co-sponsor phase III).

Latest news

  • RNA interference rebirth RNA interference rebirth

    Initial enthusiasm for therapeutics based on RNA interference (RNAi), commonly referred to as gene silencing, faced some setbacks in 2010 after some late-stage trial failures and the withdrawal of Roche ... An emerging group of companies, notably Regulus

  • Pfizer expands RNA development deal

    Santaris, which was founded in 2003, also has strategic partnerships with miRagen Therapeutics (targeting cardiovascular disease), Shire (aimed at rare genetic disorders), GlaxoSmithKline (aimed at viral diseases), and Enzon Pharmaceuticals (for

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Pharma deals during April 2013 Pharma deals during April 2013

    respectively. As a result, companies with ADC capabilities, such as Ambrx, Mersana Therapeutics and ImmunoGen, are becoming popular partner targets for pharma companies. ... Santaris/ BMS. April also saw the announcement of yet another Santaris deal,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • miRagen Therapeutics bolsters senior leadership team miRagen Therapeutics bolsters senior leadership team

    miRagen Therapeutics bolsters senior leadership team. Adam Levy and Christopher Mori take on new roles. ... Meanwhile, Mori (pictured below) brings over 25 years of strategic and operational experience to his new role at miRagen Therapeutics.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics